Onconetix Inc (ONCO) Diversifiers

Equity · Currency in USD · Last updated Jun 4, 2026

Onconetix, Inc. focuses on the research, development, and commercialization of solutions for men's health and oncology, offering products such as Entadfi, an FDA-approved pill for benign prostatic hyperplasia, and Proclarix, a protein-based blood diagnostic test for prostate cancer. The company also has a license agreement with LabCorp to develop and commercialize Proclarix and other products.

Looking to balance out your exposure to ONCO? The ETFs below have the lowest correlation with ONCO — they tend to move on their own, which can help reduce risk when ONCO drops. The stock ideas table highlights individual companies that behave independently from ONCO.

No Diversifiers Found for ONCO

We do not have enough correlation history to rank diversifiers for this symbol yet.

Diversification Analysis

Build a portfolio that complements ONCO

Add ONCO to the Diversification Analyzer to see how it overlaps with your other holdings and which assets balance it best.

Analyze a portfolio with ONCO